期刊文献+

杀菌/通透性增强蛋白N端cDNA的克隆和表达 被引量:4

Cloning and expression for cDNA of human bactericidal/permeability increasing protein N terminal fragment
下载PDF
导出
摘要 目的 克隆杀菌 /通透性增强蛋白 (BPI) N端 c DNA,构建原核和真核表达载体 ,分别在大肠杆菌和 CHO细胞中表达 BPI蛋白 .方法 提取正常人外周血多形核粒细胞 (PMN)总 RNA,经套式 RT- PCR法扩增出 BPI N端 c DNA片段 ,将其克隆入 p GEM- T easy载体中并进行酶切鉴定和序列测定 .然后亚克隆入 p GEX- 4T- 1质粒 ,转化大肠杆菌 ,进行诱导表达 ,表达产物用 Western blot法鉴定 .同时将该基因片断克隆入 pc DNA3质粒 ,通过脂质体转染 CHO细胞 ,免疫荧光法鉴定 BPI的表达 .结果 获得 BPI N端长度为 72 6 bp的基因片断 .序列分析证实该片断中有 4个点突变 ,但均不在活性中心 .在大肠杆菌中的表达产物为相对分子质量 5 1× 10 3的GST- BPI融合蛋白 ,Western blot反应中在 5 1× 10 3处有显色区带 .G418筛选出的阳性 CHO细胞在免疫荧光反应中产生荧光反应 .结论 我们成功的在大肠杆菌和 CHO细胞中表达了 BPI2 5蛋白 ,为进一步研究 AIM To clone cDNA of N terminal fragment of human bactericidal/permeability increasing protein(BPI), to construct the procaryotic and eucaryotic expression vectors and to express the cDNA in E.coli and CHO cells respectively. METHODS Total RNA was extracted from human polymorphonuclear neutrophils(PMN) and then the human BPI cDNA gene was amplified by nested RT PCR. The PCR product was cloned into pGEM T easy plasmid and the sequence was confirmed by restriction enzyme digestion and dideoxy mediated chain termination. Subsequently the specific BPI N terminal fragment was subcloned into pGEX 4T 1 plasmid and transformed into E.coli . In addition, the fragment was inserted into pcDNA3 plasmid and transformed into CHO cells with liposome transfection reagent. RESULTS A 726 bp fragment was acquired. The E.coli transformed with recombinant plasmid pGEX BPI was induced by IPTG. A 51 ku expected protein of GST BPI fusion protein was synthesized. The CHO cells transformed with pcDNA3 BPI were screened by G418, and the positive clone was obtained by using immunofluorescent assay. CONCLUSION N terminal of BPI was successfully expressed in E.coli and CHO.
出处 《第四军医大学学报》 2000年第10期1223-1226,共4页 Journal of the Fourth Military Medical University
基金 国家自然科学基金资助项目!(3980 0 15 4)
关键词 杀菌/通透性增强蛋白 克隆 基因表达 N端 CDNA bactericidal/permeability increasing protein(BPI) clone gene expression
  • 相关文献

参考文献8

  • 1[1] Weiss J, Elsbach P, Olsson I et al. Purification and characterization of a potent bactericidal/permeability-increasing protein from human polymorphonuclear leukocytes[J]. J Biol Chem, 1978; 253(8): 2664-2672.
  • 2[2] Gray PW, Flaggs G, Leong SR et al. Cloning of the cDNA of a human neutrophil bactericidal protein, Structural and functional correlations[J]. J Biol Chem, 1989; 264(16):9505-9509
  • 3[3] Weiss J, I Olsson. Cellular and subcellular localization of the bactericidal/permeability increasing protein of neutrophils[J]. Blood, 1987; 69(2): 652-659
  • 4[4] Little RG, Kelner DN,LimE et al. Functional domains of recombinant bactericidal/permeability increasing protein[J]. J Biol Chem,1994;269(3):1865-1872
  • 5[5] Horwitz AH, Leigh SD, Abrahamson S et al. Expression and characterization of cysteine-modified forms of an amino terminal fragment of bactericidal/permeability increasing protein[J]. Protein Exp Purif 1996;8:28-40.
  • 6[6] Dahlberg PS,Acton RD,Uknis ME et al. Macrophages expressing a fusion protein derived from bactericidal/permeability-increasing protein and IgG are resistant to endotoxin[J]. Arch Surg,1996;131:1173-1177.
  • 7[7] Abrahamson S, Wong P, Lim E et al. Mechanism of action of XMP antifungal peptides:Factors which influence activity and subcellular characterization[M]. Toronto:ICAAC, 1997:9-28,10-11.
  • 8[8] Horwitz AH, Motchnik P, Nadell R. Fungicidal peptides from bactericidal/permeability-increasing protein (BPI) act synergystically with fluconazole on a variety of Candida strains[M]. Toronto, ICAAC, 1997:9-28, 10-11.

同被引文献18

  • 1陈军.内毒素性急性肺损伤的研究进展[J].国外医药(抗生素分册),2005,26(3):137-141. 被引量:5
  • 2周宇麒,张天托,胡波,李林,黄静.杀菌/通透性增加蛋白N端片段在原核细胞中的表达及其临床应用的初步探讨[J].中国免疫学杂志,2005,21(5):385-389. 被引量:4
  • 3Sambrook J,Fritsch E F,M aniatis(ed).分子克隆实验指南[M].2版.北京:科学出版社,1996:888-898
  • 4Weiss J,Elsbach P,Olsson I,et al.Purification and characterization of a potent bactericidal and membrane active protein from the granules of human polymorphonuclear leukocytes[J].J Bio Chem,1978,253(8):2664-2672.
  • 5Elsbach P,Weiss J,Franson P C,et al.Separation and purification of a potent bactericidal/permeability increasing protein and a closely associated phospholipase A2 from rabbit polymorphonuclear leukocytes[J].J Biol Chem,1979,254:11000-11009.
  • 6周红.猪源杀菌性/通透性增加蛋白(BPI)的提取、纯化及其体内外生物活性的研究[D].重庆:第三军医大学,1996.
  • 7Canny G,Levy O,Furuta G T,et al.Lipid mediator induced expression of bactericidal/permeability-increasing protein (BPI) in human mucosal epithelia[J].Proc Natl Acad Sci,U S A,2002,99:3902-3907.
  • 8Reichel P H,Seemann C,Csernok E,et al.Bactericidal/permeability-increasing protein is expressed by human dermal fibroblasts and upregulated by interleukin 4[J].Clin Diagn Lab Immunol,2003,10:473-475.
  • 9Peuravuori H,Aho V V,Aho H J,et al.Bactericidal/permeability-increasing protein in lacrimal gland and in tears of healthy subjects[J].Graefes Arch Clin Exp Ophthalmol,2006,244:143-148.
  • 10Canny G O,Trifonova R T,Kindelberger D W,et al.Expression and function of bactericidal/permeability-increasing protein in human genital tract epithelial cells[J].J Infect Dis,2006,194:498-502.

引证文献4

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部